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Neisseria meningitidis
 
 is an important cause of septicaemia and meningitis. To cause disease, 
the bacterium must acquire essential nutrients for replication in the systemic circulation, 
while avoiding exclusion by host innate immunity. Here we show that the utilization of 
carbon sources by 
 
N. meningitidis
 
 determines its ability to withstand complement-mediated 
lysis, through the intimate relationship between metabolism and virulence in the bacterium. 
The gene encoding the lactate permease, 
 
lctP
 
, was identified and disrupted. The 
 
lctP
 
 mutant 
had a reduced growth rate in cerebrospinal fluid compared with the wild type, and was 
attenuated during bloodstream infection through loss of resistance against complement-
mediated killing. The link between lactate and complement was demonstrated by the 
restoration of virulence of the 
 
lctP
 
 mutant in complement (C3
 

 
/
 

 
)-deficient animals. The 
underlying mechanism for attenuation is mediated through the sialic acid biosynthesis 
pathway, which is directly connected to central carbon metabolism. The findings highlight 
the intimate relationship between bacterial physiology and resistance to innate immune 
killing in the meningococcus.
 
Neisseria meningitidis
 
 is a commensal of the hu-
man nasopharynx. However, the bacterium
occasionally enters the bloodstream where it
causes a fulminant septicaemic illness with a
10% mortality rate, or spreads to the cere-
brospinal fluid (CSF) leading to meningitis (1).
Therefore, all the pathological consequences
of meningococcal infection depend on the
bacterium’s ability to acquire nutrients for rep-
lication within the systemic circulation while
at the same time avoiding exclusion by host
innate immune mechanisms. Apart from iron
acquisition, little is known about the aspects of
microbial physiology that are critical for sur-
vival of 
 
N. meningitidis
 
 in vivo. Of the innate
immune effectors, the complement system is
critical in protection against meningococcal
infection, evident from the marked suscepti-
bility of individuals with inherited or acquired
complement deficiencies to meningococcal
disease (1).
Pathogenic 
 
Neisseria
 
 spp. are fastidious or-
ganisms that use a limited number of carbon
energy sources including glucose and lactate
(2). Both are present within the upper airway,
systemic circulation, and CSF (3, 4), niches
where 
 
N. meningitidis
 
 resides (1). In 
 
Neisseria
gonorrhoeae
 
, which causes a sexually transmitted
disease, addition of lactate at concentrations
found in vivo to media containing glucose
stimulates growth, and synthesis of protein and
LPS (3). This stimulation of metabolism results
from lactate being used solely for the produc-
tion of additional energy via acetyl-CoA and
not for gluconeogenesis, which occurs when
lactate is the sole carbon source (3). Further-
more, lactate increases the serum resistance of
 
N. gonorrhoeae
 
 by enhancing sialylation of LPS
through greater production of the substrate
and the LPS sialyl transferase (4, 5). However,
nothing is known about the effect of lactate on
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the biology of meningococcal infections. Here we describe
the identification of the 
 
N. meningitidis
 
 lactate permease
and the importance of lactate for survival of the bacterium
within the host.
 
RESULTS
NMB0543 encodes the 
 
N. meningitidis
 
 lactate permease
 
The predicted protein encoded by NMB0543 shares 21%
amino acid identity and 58% similarity with a lactate per-
mease from 
 
Escherichia coli
 
, LctP (6; Fig. 1), and is expected
to have 14 trans-membrane domains (www.tigr.org), con-
sistent with an integral membrane permease. To investi-
gate the influence of NMB0543 on lactate utilization by 
 
N.
meningitidis
 
, the growth of MC58
 

 
0543 in single carbon
sources was compared against the wild-type strain, MC58
(Fig. 2 A). Whereas the growth of the NMB0543 mutant
was indistinguishable from the wild type in 10 mM glucose,
growth of the mutant was defective in media with lactate;
the initial slight growth of MC58
 

 
0543 in lactate probably
reflects usage of amino acids such as proline as a limited en-
ergy source (7).
To examine the role of NMB0543 in lactate metabolism,
uptake studies were performed. The accumulation of 
 
14
 
C
lactate by MC58 was rapid (rising to 8.1 nmol/mg of protein
in 1 min), whereas uptake by MC58
 

 
0543 was insignificant
(Fig. 2 B), demonstrating that NMB0543 is required for as-
similation of lactate by 
 
N. meningitidis
 
. The orientation of the
open reading frames around NMB0543 (Fig. 1 A) indicates
that polar effects cannot be responsible for the phenotype of
the mutant. Furthermore, growth of MC58
 

 
0543 in lactate
was restored by complementation with a single copy of the
gene on the chromosome (Fig. S1, available at http://www.
jem.org/cgi/content/full/jem.20041548/DC1). Therefore
NMB0543 was designated 
 
lctP
 
, consistent with the 
 
E. coli
 
ortholog (6).
 
Lactate stimulation of 
 
N. meningitidis
 
 metabolism
 
As addition of lactate to medium containing glucose stimu-
lates 
 
N. gonorrhoeae
 
 growth (3, 4, 8), experiments were un-
dertaken to determine whether this also applies to 
 
N. menin-
gitidis
 
. In the presence of physiological levels of lactate (2
Figure 1. NMB0543 is a homologue of the E. coli lactate permease. 
(A) Organization of predicted open reading frames around NMB0543 and 
location of the transposon insertion in the mutant, MC580543, and a 
putative transcription stop site is marked by . (B) Alignment of the pre-
dicted amino acid sequence of NMB0543 (accession no. Q9JRD7; EMBL) 
with LctP from E. coli (accession no. P33231; SwissProt). Identical residues 
are shown with an asterisk, conserved substitutions are shown with two 
dots, and semiconserved substitutions are shown with one dot.
Figure 2. Identification of the N. meningitidis lactate permease. 
(A) Growth of wild-type N. meningitidis (MC58), and MC580543 in the 
presence of single carbon energy sources as indicated in the key. (B) Up-
take of 14C L-lactate by MC58 and MC580543. (C) Growth of MC58 in 
defined media with single carbon sources (11 mM glucose or 2 mM 
lactate), and with both (10 mM glucose or 2 mM lactate).
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mM) and glucose (10 mM), MC58 consistently emerged
from lag phase earlier (on five independent occasions;
Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20041548/DC1; P 
 
 
 
0.017) and grew more rapidly in
early log phase than in glucose only (11 mM to provide the
equivalent carbon atoms, Fig. 2 C and Fig. S2); as expected,
this stimulation of growth was not evident for MC58
 

 
lctP
 
(unpublished data). Growth in lactate (2 mM) alone was not
sustained, presumably as this carbon source was exhausted.
However in 20 mM lactate, MC58 emerged from lag phase
earlier and had an increased growth rate in log phase com-
pared with when grown in glucose alone (Fig. 2 A).
 
Lactate enhances the growth of 
 
N. meningitidis
 
 in CSF
 
A characteristic manifestation of meningococcal disease is
spread to and growth in CSF, resulting in meningitis. There-
fore, we examined the behavior of 
 
N. meningitidis
 
 wild-type
bacteria and the lactate permease mutant during growth in
CSF. MC58 grew at a faster rate than MC58
 

 
lctP
 
 (Fig. 3 A
and Fig. S2), highlighted by the changes in optical density (Fig.
3 B). Furthermore, MC58 reached a larger final biomass than
MC58
 

 
lctP
 
. 
 
1
 
H-NMR analysis demonstrated that 
 
N. meningit-
idis
 
 uses both lactate and glucose in CSF, but that lactate was
metabolized more rapidly (Fig. 4, A and B). The lactate con-
centration fell from 2.2 mM initially to 0.8 mM after 2 h
growth, and was absent after 4 h (Fig. 4 C). In contrast, glucose
levels reduced gradually, falling from 4.8 mM to 2.4 mM after
8 h. As expected MC58
 

 
lctP
 
 was unable to use lactate, but did
use glucose, with concentrations reducing from 4.8 mM to 1.6
mM after 8 h growth (Fig. 4 B). Both strains excreted acetate
during growth, with 1.5 mM and 0.4 mM acetate being accu-
mulated for MC58 and MC58
 

 
lctP
 
, respectively, indicating
activity of phospho-transacetylase acetate kinase pathway (2).
 
lctP
 
 is required for bacteraemia and avoidance of 
complement-mediated killing
 
The virulence of MC58
 

 
lctP
 
 was examined in the infant rat
model of bacteraemia. This model has been used to study the
Figure 3. Growth of N. meningitidis in CSF. (A) Growth of wild-type 
N. meningitidis MC58 (open squares) and MC58lctP (solid diamonds) in 
CSF. (B) The half hourly changes in optical density of cultures (A600) are 
shown. The difference in the growth of the strains is statistically signifi-
cant (Student’s t test comparing changes in OD of the strains, P  0.025).
Figure 4. Utilization of carbon sources by N. meningitidis in CSF. 
(A) MC58 and (B) MC58lctP were grown in CSF and the effect on carbon 
content was analyzed by 1H-NMR. The peaks representing individual carbon 
sources are labeled. The time (in hours) when samples were taken during 
growth is indicated. (C) The percentage of lactate and glucose remaining 
in CSF during growth of MC58.
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role of meningococcal genes during systemic infection, a
critical step in pathogenesis. The competitive index (C.I.) of
MC58
 

 
lctP
 
 (0.108, P
 
  
 
0.01; Fig. 5) demonstrates that this
strain is markedly attenuated in its ability to cause sustained
bacteraemia compared against the wild-type strain. The vir-
ulence of the mutant was restored in the complemented
strain, MC58
 

 
lctP
 
::
 
lctP
 
ect
 
 (Fig. 5).
To proliferate in the systemic circulation 
 
N. meningitidis
 
must resist innate immune killing mechanisms. Therefore,
we examined the sensitivity of MC58
 

 
lctP
 
 to complement.
The survival of MC58
 

 
lctP
 
 in normal human sera was only
16% that of the wild type, whereas there was no significant
difference in the survival of strains in heat-treated serum
(Fig. 6 A and Fig. S3,
 
 
 
available at http://www.jem.org/cgi/
content/full/jem.20041548/DC1). Complementation of
MC58
 

 
lctP
 
 with the wild-type allele of the gene demon-
strated that loss of LctP was solely responsible for the serum
sensitivity of MC58
 

 
lctP
 
 (Fig. 6 B).
All pathways of complement activation lead to cleavage
of C3 to C3a and C3b, which binds to cell surfaces leading
to opsonization and/or assembly of the membrane attack
complex and bacteriolysis. We therefore compared the
amount of C3 binding to wild-type 
 
N. meningitidis
 
 and the
lactate permease mutant. There was a significantly increased
C3 binding to the lactate permease mutant (P 
 
 
 
0.001; Fig.
Figure 5. The lactate permease mutant is attenuated during 
bloodstream infection. Competitive indices (C.I.) of the lactate permease 
mutant (MC58lctP) and the complemented strain (MC58lctP::lctPect) 
in the infant rat model. Error bars show the standard deviation.
Figure 6. LctP is required for resistance against complement-
mediated lysis. (A) Relative resistance of MC58lctP to complement-
mediated lysis compared with MC58 in 50% normal human serum (NHS) 
or heat inactivated serum (HIS). The error bars show the standard error of 
the mean. (B) Complementation of MC58lctP restores resistance against 
serum-mediated killing. (C) FACS analysis demonstrates that C3 deposition 
on MC58lctP is higher than MC58. (D), The competitive index (C.I.) of 
wild type and lactate permease strain in wild-type and C3/ mice. The 
virulence of MC58lctP is restored in complement deficient animals.
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6 C and Fig. S4, available at http://www.jem.org/cgi/con-
tent/full/jem.20041548/DC1), consistent with its enhanced
sensitivity to complement-mediated lysis.
The lctP mutant is attenuated through its inability to 
withstand complement-mediated killing
The attenuation of the lctP mutant during bacteraemic infec-
tion could either have been due to a defect in growth (as in the
CSF; Fig. 3 A), or increased susceptibility to complement-
mediated lysis (as in the serum killing assays, Fig. 6 A). To dif-
ferentiate between these possibilities, the virulence of the lctP
mutant was determined in animals lacking an intact comple-
ment system. We measured the C.I. of MC58lctP in congenic
C3/ and C3/ mice 20 h after infection, the time of maxi-
mum bacteraemia. The results (Fig. 6 D) demonstrate that the
virulence of the lctP mutant is restored to wild-type levels in
the absence of C3. Thus, during bacteraemia, lctP influences
the behavior of N. meningitidis through its effect in preventing
complement-mediated killing and not bacterial growth.
Sensitivity of the lctP mutant to complement remains in the 
absence of capsule
A major mediator of complement resistance in serogroup B N.
meningitidis is the polysaccharide capsule (9, 10). Therefore the
effect of loss of lctP was evaluated in a strain lacking siaD, which
encodes the polysialyltransferase required for capsule biogenesis
(11). Loss of encapsulation resulted in a marked increase in sus-
ceptibility to complement-mediated killing, therefore assays
with unencapsulated strains were performed with lower con-
centrations of serum (3%) than encapsulated strains (50%); intro-
duction of the wild-type allele of siaD restored resistance to
complement to the level of MC58 (unpublished data). Never-
theless, the difference in complement sensitivity of a strain with
(MC58siaD) or without lctP (MC58siaDlctP) was still evi-
dent in a capsule negative background (Fig. 7 and Fig. S5, avail-
able at http://www.jem.org/cgi/content/full/jem.20041548/
DC1), demonstrating that lctP influences serum resistance even
in the absence of the polysaccharide capsule.
LctP contributes to LPS sialylation
Sialylation of LPS contributes to serum resistance of patho-
genic Neisseria spp. (3–5). We examined the effect of lactate
availability in unencapsulated strains that are unable to sialylate
LPS (MC58siaDlst and MC58siaDlstlctP). Loss of
LctP had no significant impact on resistance to complement-
mediated killing in strains that are unable to sialylate their LPS
(Fig. 8 A and Fig. S6, available at http://www.jem.org/cgi/
content/full/jem.20041548/DC1) indicating that lctP contrib-
utes to resistance to complement killing through LPS sialyla-
tion. Therefore, we examined the extent of LPS sialylation of
strains. Whole cell extracts from MC58, MC58lst and
MC58lctP were analyzed by SDS-PAGE and immunoblot-
ting using an antibody against LPS (Fig. 8 B) and a mAb, 3F11
(Fig. 8 C), which recognizes the terminal Gal1-4GlcNAc
epitope in the lacto-N-neotetraose moiety of LPS and there-
fore detects unsialylated LPS (12). The binding of the anti-
body against LPS was similar for all strains, as was the binding
of 3F11 to neuraminidase-treated samples (Fig. 8 D). How-
ever, there was increased binding of 3F11 to the lst and lctP
mutant compared with MC58, demonstrating that the LPS of
MC58lctP is less sialylated than in the wild-type strain, con-
sistent with its increased susceptibility to complement.
Available lactate affects resistance to complement-
mediated lysis through a link between the sialic acid 
biosynthesis pathway and intermediary metabolism
We next investigated the basis by which lack of lactate re-
sults in the increased sensitivity to complement. In N. menin-
Figure 7. LctP contributes to complement sensitivity in the 
absence of capsule. Relative resistance to complement of strains lacking 
capsule with (strain MC58siaD, shown by LctP) or without 
(MC58siaDlctP, indicated with LctP) the lactate permease. Assays 
were performed in the presence of human serum (3%, error bars indicate 
the standard error of the mean).
Figure 8. LctP influences LPS sialylation. (A) Relative resistance to 
complement of strains lacking capsule and unable to sialylate their LPS 
with (MC58siaDlst) or without (MC58siaDlstlctP) the ability to 
utilize lactate. Error bars indicate the standard error of the mean. Western 
blot of cell lysates of strains (shown above each lane) probed with mAbs 
against (B) total LPS (L3,7,9), and a mAb against unsialylated LPS (3F11) 
before (C) or after (D) neuraminidase treatment. White lines indicate that 
intervening lanes have been spliced out.
LACTATE AND RESISTANCE TO COMPLEMENT | Exley et al.1642
gitidis, sialic acid is predicted to be synthesized from N-acetyl
mannosamine and phosphoenol pyruvate (PEP; Fig. 9 A), a
reaction catalyzed by the enzyme SiaC, encoded on the hor-
izontally acquired capsule biosynthesis locus (13). PEP can
be formed by a circuitous route from glucose via the Entner
Doudoroff pathway (2). In contrast, PEP is generated di-
rectly from lactate after conversion to pyruvate (Fig. 9 A),
providing a potential connection between lactate availability
and resistance against complement-mediated lysis. There-
fore, the lctP mutation was introduced into a strain lacking
siaC. There was no significant difference in complement sus-
ceptibility between strains with and without LctP in a siaC-
negative background (Fig. 9 B and Fig. S7, available at http://
www.jem.org/cgi/content/full/jem.20041548/DC1), con-
sistent with the sialic acid biosynthesis pathway acting as a
link between lactate availability, and resistance against com-
plement-mediated lysis.
DISCUSSION
To produce disease, N. meningitidis and N. gonorrhoeae must
replicate in environments that contain mixtures of lactate
and glucose. This report is the first description of a mutant of
Neisseria that is unable to assimilate or use lactate. Attempts
to investigate lactate metabolism through inactivation of lac-
tate dehydrogenase would be difficult given the multiple iso-
forms of this enzyme in N. meningitidis and N. gonorrhoeae (5,
14–16). Thus, the identification of the lactate permease mu-
tant is valuable for investigating the influence of this carbon
source on pathogenesis, particularly when it cannot be ex-
cluded from virulence assays such as experiments in vivo.
As N. gonorrhoeae (3), the meningococcus emerges earlier
from lag phase and grows more rapidly when lactate is added
to media containing glucose. In the CSF, lactate and glucose
are both metabolized by N. meningitidis with lactate used pref-
erentially. In addition, we observed an increased growth rate
of the wild-type strain compared with the lctP mutant in CSF.
During meningeal infection, acquisition of lactate may en-
hance meningococcal growth. This effect might be more pro-
nounced during active meningitis when CSF lactate levels are
replenished and rise to over 3.8 mM whereas glucose concen-
trations fall (17). The activity of the phospho-transacetylase
acetate kinase pathway (2), shown by the production of
acetate, may also be relevant as the pathway results in the pro-
duction of acetyl phosphate, a phosphate donor to two com-
ponent regulatory systems such as PhoP/PhoQ, which is in-
volved in gene regulation during pathogenesis (18, 19).
During bloodstream infection, the lctP mutant is signifi-
cantly attenuated. As the virulence of the lctP mutant was re-
stored to wild-type levels in complement deficient animals,
we demonstrate that the lack of resistance to innate immune
killing is responsible for the attenuation of the lctP mutant,
rather than reduced growth. Therefore lactate availability ap-
pears to have a dual role during pathogenesis. In the CSF
where there are few complement components, lactate con-
tributes to bacterial growth, while in contrast, available lactate
contributes to resistance against complement during bacter-
aemic infection. The sensitivity of the lactate permease mutant
to complement was still observed in a capsule-negative mu-
tant. Our results demonstrate that inability to import lactate
reduces LPS sialylation, and suggest that this is responsible for
the increased susceptibility to complement-mediated lysis. In
N. gonorrhoeae, sialylation is important for conferring resistance
against complement (20) by blocking deposition of comple-
ment components and/or antibodies to the bacterial cell sur-
face (21), or by influencing factor H binding, inhibiting the al-
ternate pathway of complement activation (22). There is
conflicting evidence about the role of LPS sialylation in N.
meningitidis. Although there is a clear correlation between re-
sistance to complement and LPS sialylation among clinical iso-
lates (23), mutants lacking lst do not exhibit enhanced sensitiv-
ity to this important innate immune mechanism (24).
Our findings with the siaC-negative strain (Fig. 8 B) in-
dicate that available lactate is directed through the sialic acid
biosynthesis pathway to enhance resistance against comple-
ment-mediated lysis. Although glucose can also be con-
verted into PEP (and thence sialic acid), this occurs via the
Entner Doudoroff pathway (2), and not through a direct
route as when lactate is the carbon source. This provides an
Figure 9. The metabolic fate of lactate in N. meningitidis. (A) Inter-
mediary metabolism in MC58 with enzymes encoded on the horizontally 
acquired, capsule biosynthesis locus shown in dotted arrows. (B) Relative 
resistance to complement of MC58siaC and MC58siaClctP. Assays 
were performed in 3% human serum, and the error bar shows the stan-
dard error of the mean.
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explanation of how lactate contributes to resistance against
complement-mediated killing. Lactate utilization could also
lead to other changes in the bacterium aside from LPS sial-
ylation, such as enhanced capsulation, although the effect of
lactate on resistance against complement was still observed in
nonencapsulated strains. In the gonococcus, additional lac-
tate induces changes in the amount and structure of LPS (3,
5). Full structural analysis is required to detail all the effects
of lactate on N. meningitidis LPS.
Within the host, pathogenic bacteria must successfully ac-
quire key nutrients from the microenvironment that are re-
quired for their growth and integrity in vivo. Our results pro-
vide an example of the intimate relationship between carbon
source availability and the expression of specific virulence de-
terminants by N. meningitidis. This relationship involves a link
between intermediary metabolism and enzymes encoded by
the capsule biosynthesis locus, a pathogenicity island, result-
ing in evasion of innate immune killing by the complement
system. This raises three important points. First, functions en-
coded by horizontally acquired elements can confer signifi-
cant benefit to a pathogen through integration with interme-
diary metabolism; this may be crucial for providing the
bacterium scope to explore further niches in the host. Sec-
ond, metabolism and virulence cannot be considered as dis-
tinct functions within the bacterial cell. Finally, a novel class
of antimicrobial compounds and vaccines could be designed
that block nonessential metabolic pathways and render the
bacterium more sensitive to innate immune killing.
MATERIALS AND METHODS
Bacterial strains and growth. The bacterial strains and plasmids used in
this study are shown in Table I. N. meningitidis was grown on Brain Heart In-
fusion medium with Levanthal’s supplement in the presence of 5% CO2 at
37C. E. coli was grown on Luria Bertani medium. Antibiotics were: 50 and
75 g/ml1 kanamycin; 200 and 2 g/ml1 erythromycin; and 25 and 2.5 g
ml1 tetracycline for E. coli and N. meningitidis, respectively. For studies on
lactate metabolism, strains were grown in meningococcal chemically defined
medium consisting of modified Jyssums minimal media (2) with 1.4 mM argi-
nine, 0.06 mM cysteine, 1 mM glutamate, and 1 mM glycine. Glucose and
lactate were added to the media as specified. Growth was measured by read-
ing optical density at 600 nm, and growth rates were calculated as the differ-
ence in values over specified intervals and shown as changes in optical density.
Generation of N. meningitidis mutants. An NMB0543 (www.tigr.org)
mutant was constructed in MC58 by amplifying the defective allele from
Table I. Bacterial strains and plasmids used in this study
Strains/plasmid Genotype/description Reference
N. meningitidis
 MC58 Wild-type serogroup B 12
 MC580543
MC58lctP Insertional inactivation of lctP
This study
 MC58lst Insertional inactivation of lst This study
 MC58siaD Insertional inactivation of siaD This study
 MC58siaDlctP Insertional inactivation of lctP, siaD This study
 MC58siaDlstlctP Insertional inactivation of lctP, lst, siaD This study
 MC58siaC Insertional inactivation of siaC This study
 MC58siaClctP Insertional inactivation of siaC and lctP This study
 MC58lctP::lctPect Complemented MC58lctP
E. coli
 DH5 F	 endA1 supE44 thi-1 hsdR17(rK mK) recA1 
gyrA relA1 (lacIZYA-argF) U169 deoR
(
80dlac[lacZ]M15)
GIBCO-BRL
Plasmids
 pCR TOPO 2.1 Cloning vector Invitrogen
 pIP10 siaDery 28
 pYHlctP Cloned lctP of N. meningitidis This study
 pSTlst lst interrupted by tetM This study
 pSTsiaC siaC interrupted by tetM This study
 pYHS25 Vector for complementation 29
 pRME104 pYHS25 containing lctP This study
 pRME105 pYHS25 containing siaD This study
 pRME106 pYHS25 containing lst This study
 pRME107 pYHS25 containing siaC This study
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mutant 9B10 identified by signature-tagged mutagenesis (25), and using the
2.9-kb product to transform MC58. To generate an lst mutant, 500 b.p.
upstream and downstream fragments of NMB0922, which encodes the -2,
3 LPS sialyl transferase (26), were amplified from strain MC58, ligated into
pST-Blue (Novagen); the tetM cassette (encoding tetracycline resistance)
was obtained from pJS1845 (gift from D. Stephens, Emory University, At-
lanta, GA; reference 27) and introduced between the up- and downstream
fragments. The siaC mutant was constructed using the same strategy but us-
ing pCRTopo2.1 as the vector. Details of the oligonucleotides used in this
study are given in Table S1 available at http://www.jem.org/cgi/content/
full/jem.20041548/DC1. Capsule-negative mutants were constructed by
transforming strains with pIP10 (28), which contains an internal deletion of
siaD (encoding the -2, 8 polysialyl transferase) replaced with an erythro-
mycin-resistance cassette.
For complementation, lctP, lst, siaC, and siaD were amplified from
MC58 with High Fidelity Expand Taq (Boehringer), and the products li-
gated into pCR Topo 2.1, excised and then introduced into a multiple
cloning site in pYHS25, downstream of an opa promoter. This vector con-
tains the promoter, multiple cloning site and ermC flanked by fragments of
NMB0102 and NMB0103 (29). After transformation of N. meningitidis,
integration of the vector by double crossover leads to a single chromo-
somal copy of the complementing gene in the intergenic region between
NMB0102 and NMB0103, which are open reading frames orientated in a
tail-to-tail fashion. The inserts in plasmids used for complementation were
verified by nucleotide sequencing. All transformants were analyzed by
Southern hybridization (unpublished data). Each mutation was backcrossed
into the parental strain, and multiple colonies were pooled to exclude any
effects of phase variation. Complementation of siaC and siaD restored resis-
tance against complement to wild-type levels (unpublished data) whereas
complementation of lst restored sialylation of LPS (Fig. S9, available at http:
//www.jem.org/cgi/content/full/jem.20041548/DC1).
Uptake of lactate and metabolism in CSF. The uptake of lactate by
bacteria was measured as described previously (30) in bacteria grown to mid-
exponential phase in meningococcal chemically defined medium containing
10 mM glucose and 1 mM DL-lactate. CSF was obtained from uninfected
patients (provided by Microbiology Laboratories, Royal Hallamshire Hospi-
tal with approval of the Local Ethical Committee). Bacteria (108 CFU) were
inoculated from overnight growth into 10 ml of CSF and incubated at 37C
in 5% CO2. Samples were removed at intervals, the bacteria pelleted by cen-
trifugation (10,000 g for 2 min), and the supernatant filtered (0.45 m pore)
before analysis by 1H-NMR (at 500 MHz; DRX500 spectrometer; Bruker).
Signals were integrated using FELIX 2000 (Accelrys Inc.).
Virulence assays. To examine the effect of lctP on virulence, mixed litters
of 5-d-old rats (Wistar) were inoculated i.p. with 107 CFU of N. meningiti-
dis in 100 l PBS. Bacteria were grown overnight on solid media, resus-
pended in PBS, and then enumerated by measuring the A260 of an aliquot of
the suspension in lysis buffer (1% SDS/0.1 M NaOH). The virulence of the
lctP mutant was compared directly with MC58 in individual animals given a
1:1 ratio of wild-type to mutant bacteria. The number of mutant (kanR) and
wild-type bacteria recovered from the blood of animals 24 h later was estab-
lished by plating to media with and without kanamycin. The C.I. was cal-
culated as the (number of mutant/wild-type bacteria recovered from ani-
mals)/(number of mutant/wild-type bacteria in the inoculum).
C.I.s were also determined in the murine model of bacteraemia (31) as
no C3/ infant rats are available. C3/ and C3/ mice were backcrossed
to the C57BL/6 background for over 10 generations. Female, 6-wk-old
mice received 104 CFU of each strain i.p. in Brain Heart Infusion/0.5%
iron dextran, and bacteria recovered by tail vein bleeding 20–24 h later.
Studies with animals were approved under a Home Office project licence.
Complement-mediated bacteriolysis, C3 binding, and LPS analysis.
Bacteria were harvested from solid media, and 5  108 CFU were inocu-
lated in 10 ml DMEM with glucose (25 mM), lactate (2 mM), and 100 M
CMP-neuraminic acid (CMP-NANA; Sigma) and grown for 2 h at 37C in
the presence of 5% CO2 with gentle agitation. For complement-mediated
bacteriolysis assays, the cells were harvested by centrifugation at 20,000 g,
and then 100 l aliquots containing 104 CFU were incubated with serial di-
lutions of normal human sera for 1 h at 37C. The number of bacteria in the
inoculum and after incubation with serum was determined by plating to
solid media; assays were performed in duplicate and at least on three inde-
pendent occasions. Heat-inactivated sera was used in control assays. Figures
show the percentage survival of bacteria lacking the lactate permease against
the corresponding strain expressing the permease. Student’s t test analysis
was performed to indicate significant differences.
To measure C3 deposition, bacteria were grown as above, collected by
centrifugation at 20,000 g, fixed in 3% paraformaldehyde for 15 min, and
then washed twice in PBS. Next, 107 bacteria in 100 l were incubated
with dilutions of serum for 30 min at 37C, washed twice then resuspended
in PBS/0.1% Tween 20 containing a FITC-conjugated goat anti-C3 anti-
body (1:300 dilution; ICN Biomedicals) and incubated for 30 min. After
washing in PBS-Tween 0.1%, fluorescence was measured using a FACS
Calibur analyzer (Becton Dickinson). Results are presented as the relative
fluorescence index (the percentage of positive cells multiplied by the geo-
metric mean fluorescence) of MC58lctP with respect to wild-type bacte-
ria; significant difference was examined with a Student’s t test.
For LPS analysis, cells were grown in liquid media as above and cell ex-
tracts prepared as follows. Bacteria were enumerated, pelleted by centrifuga-
tion and resuspended in SDS-PAGE loading buffer (50 mM Tris HCl pH
6.8, 2% SDS-PAGE, 10% glycerol, 1.1% bromophenol blue, 100 mM
-mercaptoethanol) to a concentration of 1010 CFU ml1. Extracts were
boiled for 10 min before SDS-PAGE analysis. LPS was detected using
-L3,7,9 mAb (at a dilution of 1:500; NIBSC), and unsialylated LPS de-
tected with mAb 3F11 (1:100; gift from M. Apicella, University of Iowa,
Iowa City, IA). Binding of a secondary antibody (1:1,000, antimurine im-
munoglobulin conjugated to HRP; DakoCytomation) was detected using
the ECL system (Amersham Biosciences). For neuraminidase-treated ex-
tracts, the same procedure was followed except bacteria were resuspended
in 50 mM sodium citrate, pH 6.0, at a concentration of 1010 CFU ml1, and
then incubated for 1 h at 37C with 50 U neuraminidase (New England
Biolabs) before lysis in SDS-PAGE buffer.
Online supplemental material. The results of individual bacteriolysis as-
says and C3 binding are shown as well data relating to bacterial growth. The
orientation of reading frames around relevant genes, list of oligonucleotides,
and details of complementation are also provided. Available at http://
www.jem.org/cgi/content/full/jem.20041548/DC1.
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